Intel upsized its common stock offering to $20 billion on August 10, raising $19.7 billion net after underwriting fees. The chipmaker initially announced a $15 billion offering but saw institutional demand swell to approximately $100 billion, prompting management to increase the size. Shares priced at $95 per share—a 6.5% discount to Friday's close—and the offering closed August 12. Intel's stock has surged 175% so far in 2026 and quintupled over the past year, making equity issuance far more palatable than debt.
Intel intends to use proceeds for general corporate purposes including capital expenditures and working capital. The company raised its 2026 capex guidance to $20 billion from $18 billion in July, citing unprecedented customer demand for AI compute. Advanced packaging, purpose-built silicon for agentic AI workloads, and expanded wafer capacity are among named growth vectors. Tesla has signed on as a customer for Intel's 14A process node, with high-volume production targeted for 2028. Analysts framed the capital raise as a signal that major foundry customers are near—deals so large Intel needed to build capacity preemptively.
For practitioners tracking AI chip ecosystem financing: Intel's $20B equity raise underscores the structural capital intensity of competing in advanced process nodes and foundry services. The institutional order book's 5x oversubscription signals conviction that foundry demand and process roadmaps will justify the spend—a direct bet on Intel's competitive positioning versus TSMC in the next-generation AI accelerator market.